Top compounds associated with response to GDF3


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.079 0.02
mRNA Gemcitabine gCSI pan-cancer AAC -0.13 0.02
mRNA paclitaxel CCLE pan-cancer AAC -0.1 0.02
mRNA Crizotinib CCLE pan-cancer AAC -0.1 0.02
mRNA MG-132 GDSC1000 pan-cancer AAC 0.14 0.02
mRNA pac-1 CTRPv2 pan-cancer AAC -0.081 0.02
mRNA GSK269962A GDSC1000 pan-cancer AAC -0.088 0.02
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.079 0.02
mRNA KIN001-236 GDSC1000 pan-cancer AAC 0.09 0.02
mRNA PI-103 CTRPv2 pan-cancer AAC -0.077 0.02
Download CSV